Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients

NEXT STORY
Insights on the Peptic Ulcer Testing Global Market to 2027 – Featuring Biohit OYJ, Biomerica & bioMrieux Among Others
PREV STORY
NCLA, Gov. Baker File Petition Asking Mass. Supreme Judicial Court to Hear Civil Defense Act Case
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global IVD Procedure Volumes Report 2021: Volume of IVD Procedures is Forecast to Increase 7.9% Annually to 111.3 Billion in 2025

author_avatar
NASDAQ Market News

Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19

author_avatar
NASDAQ Market News

T2 Biosystems Announces New Data at ASM Microbe 2016 Demonstrating Benefits of Adopting T2Candida® Panel for Diagnosing Sepsis in Clinical Settings

LEXINGTON, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company ...

author_avatar
NASDAQ Market News